Novartis AG vs Paycom Software Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Paycom Software Inc trades at $144.05 (market cap $6.98B). The key difference: Novartis AG is far larger — about 41.6× Paycom Software Inc's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | PAYC | |
|---|---|---|
Market Cap | $290.25B | $6.98B |
Sector | Health | Technology |
52-Week High | $168.62 | $238.80 |
52-Week Low | $113.50 | $113.59 |
Enterprise Value | $330.27B | $7.59B |
Dividend Yield | 3.17% | 1% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →